Resource Center: Hepatitis
Results 1 - 10 of 11
Search Results
Description:
This chapter of TIP 43 is aimed to help treatment providers identify co-occurring medical problems in patients who are addicted to opioids.
Source:
Substance Abuse and Mental Health Association (SAMHSA) (3 votes)
Tags:
Description:
This set of guidelines aids physicians in providing detoxification and substance abuse treatment, specifically examining co-occurring medical and psychiatric conditions.
Source:
Substance Abuse and Mental Health Services Administration (SAMHSA) (3 votes)
Description:
This research report from NIDA discusses the scope of heroin use in the US, immediate and long term effects of heroin use, the medical complications of heroin use, how heroin abuse affects pregnant women, and more. It also discusses treatments for heroin addiction, including buprenorphine.
Source:
National Institute on Drug Abuse (NIDA) (3 votes)
Tags:
Description:
This web page provides brief recommendations for monitoring patients undergoing buprenorphine treatment using liver function tests, and the proper actions to take if a patient develops hepatitis.
Source:
PCSS Guidance
Tags:
Description:
This website, funded by SAMHSA, is designed to help physicians to implement office-based buprenorphine treatment using a national network of trained physician mentors.
Source:
Physician Clinical Support System (PCSS) (2 votes)
Tags:
- General information - buprenorphine
- Getting a waiver/setting up your practice
- Logistics of buprenorphine treatment
- Addiction
- Behavioral therapy
- Billing
- Complicated patients
- Contraindications
- CPT
- Diversion
- Dosing
- Drug interactions
- HCPCSs
- Hepatitis
- HIV/AIDS
- Induction
- Methadone
- Pain
- Pregnant
- Psychiatric
- Psychosocial
- Special populations
- Suboxone
- Just became waivered
- Setting up a practice
Description:
This document discusses the evidence for buprenorphine treatment of opioid dependent adolescents and young adults. It provides treatment recommendations, and highlights special issues that should be considered when treating this special population.
Source:
Physician Clinical Support System (PCSS)
Tags:
- General information - buprenorphine
- Induction and dosing
- Stabilization and maintenance
- Special populations
- Addiction
- Adolescents
- Comorbidities
- Dependence
- Detoxification
- Diagnosis
- Dosing
- Hepatitis
- Heroin
- HIV/AIDS
- Induction
- Maintenance
- Overdose
- Precautions
- Psychosocial
- Relapse
- Side effects
- Special populations
- Suboxone
- Withdrawal
- Treatment Algorithm
- Experienced prescriber
- Just became waivered
Description:
Discussing the psychosocial aspects of treatment in patients receiving Buprenorphine/Naloxone
Source:
Physician Clinical Support System (PCSS) (3 votes)
Tags:
Review of Systems
Description:
Conducting a Review of Systems When completing a Review of Systems, look for the following complications that are common among opioid abusers.
Health Risks of Opioid Use
Description:
Covering some of the health problems that are associated with opioid use and dependence.
This patient handout explains some of the health problems that are associated with opioid use and dependence, including specific diseases.
Tags:
Description:
A wealth of information from the CDC about the types of hepatitis viruses, including HBV and HCV.
Source:
Centers for Disease Control and Prevention (CDC) Development of this website was funded entirely by grant #R44DA12066 and contract #HHSN271200655304C from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The website contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA. Ongoing development and maintenance is funded by the training fee and Clinical Tools, Inc. This site is for educational purposes only and medical decisions should not be based solely on its content. This site, its authors, and its consultants do not assume liability for errors or omissions. Copyright and Reproduction Guidelines | Privacy Policy | Terms of Service | Technology Requirements |
Tuesday, February 7, 2012 - 3:13pm
|
